Koyfin Home > Directory > Health Care > Akcea Therapeutics Inc > Price / Earnings (ntm)

Akcea Therapeutics Inc Price / Earnings (ntm) Chart (AKCA)

Akcea Therapeutics Inc annual/quarterly Price / Earnings (ntm) from 2018 to 2018. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Akcea Therapeutics Inc Price / Earnings (ntm) for the quarter ending November 11, 2018 was 66.39
  • Akcea Therapeutics Inc Price / Earnings (ntm) for the last 12 months ending November 11, 2018 was 66.39
  • Akcea Therapeutics Inc Annual Price / Earnings (ntm) for 2018 was 66.39 a -145.24% decrease of -96.42 from 2017
  • Akcea Therapeutics Inc Annual Price / Earnings (ntm) for 2018 was 162.81
Other Valuation Metrics:
  • Akcea Therapeutics Inc Market Cap for the quarter ending March 03, 2018 was $1,709m
  • Akcea Therapeutics Inc Price / Book for the quarter ending March 03, 2018 was 9.49
  • Akcea Therapeutics Inc Enterprise Value for the quarter ending March 03, 2018 was $1,449m
View Chart On Koyfin

Quarterly AKCA Price / Earnings (ntm) Data

11/201866.39
08/2018162.81

Annual AKCA Price / Earnings (ntm) Data

201866.39
2018162.81